Sirtaz Adatya, MD
Cardiovascular Disease (Cardiology) · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Adatya’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence C150453 · Current
Licensed to practise in California · since 2017 · expires 2027-03-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 036136680Licensed Physician And Surgeon · since 2014 · expires 2017-07-31Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Drugs they prescribed that Part D paid
$92,144
Pharmacies billed $92,144 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
186 generic and 86 brand-name prescriptions · $92,144 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Entresto | 31 | $49,654 | $1,602 |
| Jardiance | 26 | $13,827 | $532 |
| Ozempic | 13 | $9,629 | $741 |
| Spironolactone | 27 | $256 | $9 |
| Carvedilol | 23 | $242 | $11 |
See all 7 drugs
| Entresto | 31 | $49,654 | $1,602 |
| Jardiance | 26 | $13,827 | $532 |
| Ozempic | 13 | $9,629 | $741 |
| Spironolactone | 27 | $256 | $9 |
| Carvedilol | 23 | $242 | $11 |
| Metoprolol | 11 | $172 | $16 |
| Digoxin | 16 | $172 | $11 |
Year by year
| 2024 | 272 | 42 | None | 32% | $92,144 |
| 2023 | 372 | 45 | 0% (0) | 34% | $165,294 |
| 2022 | 295 | 40 | 0% (0) | 40% | $106,746 |
| 2021 | 107 | 23 | 0% (0) | 58% | $45,044 |
| 2020 | 148 | 26 | 0% (0) | 32% | $91,908 |
| 2019 | 148 | 34 | 0% (0) | 34% | $95,965 |
| 2018 | 124 | 33 | 0% (0) | None | $17,138 |
| 2017 | 421 | 51 | None | 21% | $186,635 |
| 2016 | 668 | 65 | 2% (13) | 22% | $219,935 |
| 2015 | 471 | 75 | None | 12% | $38,219 |
| 2014 | 528 | 68 | None | None | $27,168 |
| 2013 | 171 | 51 | None | None | $12,392 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Entresto | 57 | $67,831 | $1,190 |
| Jardiance | 43 | $30,133 | $701 |
| Carvedilol | 39 | $445 | $11 |
| Bumetanide | 11 | $437 | $40 |
| Amiodarone | 15 | $380 | $25 |
| Metoprolol | 19 | $355 | $19 |
| Spironolactone | 38 | $344 | $9 |
| Digoxin | 17 | $286 | $17 |
2022: 7 drugs
| Entresto | 49 | $54,994 | $1,122 |
| Jardiance | 51 | $31,290 | $614 |
| Hydralazine | 14 | $597 | $43 |
| Bumetanide | 11 | $480 | $44 |
| Carvedilol | 27 | $315 | $12 |
| Spironolactone | 21 | $220 | $10 |
| Isosorbide Mononitrate Er | 11 | $123 | $11 |
2021: 2 drugs
| Entresto | 21 | $20,041 | $954 |
| Jardiance | 24 | $14,864 | $619 |
2020: 3 drugs
| Entresto | 19 | $10,276 | $541 |
| Hydralazine | 21 | $714 | $34 |
| Carvedilol | 21 | $241 | $11 |
2019: 3 drugs
| Entresto | 19 | $16,249 | $855 |
| Digoxin | 12 | $283 | $24 |
| Hydralazine | 11 | $150 | $14 |
2018: 2 drugs
| Furosemide | 12 | $258 | $21 |
| Spironolactone | 12 | $138 | $12 |
2017: 9 drugs
| Lantus Solostar | 19 | $7,318 | $385 |
| Dofetilide | 11 | $4,048 | $368 |
| Carvedilol | 16 | $285 | $18 |
| Hydralazine | 11 | $211 | $19 |
| Spironolactone | 21 | $178 | $8 |
| Pravastatin | 11 | $170 | $15 |
| Atorvastatin | 13 | $151 | $12 |
| Lisinopril | 15 | $132 | $9 |
| Amlodipine Besylate | 11 | $73 | $7 |
2016: 18 drugs
| Lantus Solostar | 28 | $10,654 | $380 |
| Tacrolimus | 17 | $3,904 | $230 |
| Mycophenolate Mofetil | 13 | $1,020 | $78 |
| Pravastatin | 32 | $603 | $19 |
| Metoprolol | 18 | $384 | $21 |
| Losartan | 12 | $322 | $27 |
| Spironolactone | 23 | $279 | $12 |
| Prazosin | 11 | $268 | $24 |
| Clopidogrel | 17 | $253 | $15 |
| Levothyroxine | 20 | $246 | $12 |
| Allopurinol | 22 | $224 | $10 |
| Carvedilol | 14 | $168 | $12 |
| Warfarin | 14 | $136 | $10 |
| Atorvastatin | 15 | $128 | $9 |
| Lisinopril | 18 | $117 | $6 |
| Omeprazole | 16 | $107 | $7 |
| Hydrochlorothiazide | 15 | $102 | $7 |
| Furosemide | 23 | $87 | $4 |
2015: 17 drugs
| Sirolimus | 17 | $11,327 | $666 |
| Mycophenolate Mofetil | 20 | $4,211 | $211 |
| Potassium Chloride | 19 | $2,260 | $119 |
| Pravastatin | 31 | $831 | $27 |
| Hydralazine | 12 | $595 | $50 |
| Warfarin | 23 | $531 | $23 |
| Torsemide | 12 | $410 | $34 |
| Carvedilol | 24 | $311 | $13 |
| Amlodipine Besylate | 28 | $191 | $7 |
| Simvastatin | 24 | $148 | $6 |
| Isosorbide Mononitrate Er | 11 | $146 | $13 |
| Pantoprazole | 15 | $114 | $8 |
| Jantoven | 13 | $92 | $7 |
| Lisinopril | 12 | $91 | $8 |
| Furosemide | 23 | $78 | $3 |
| Spironolactone | 14 | $71 | $5 |
| Metoclopramide | 11 | $50 | $5 |
2014: 17 drugs
| Isosorbide Dinitrate | 14 | $1,260 | $90 |
| Mycophenolate Mofetil | 20 | $1,202 | $60 |
| Metoprolol | 35 | $754 | $22 |
| Hydralazine | 18 | $653 | $36 |
| Pravastatin | 31 | $508 | $16 |
| Potassium Chloride | 13 | $343 | $26 |
| Torsemide | 13 | $329 | $25 |
| Isosorbide Mononitrate Er | 14 | $260 | $19 |
| Carvedilol | 27 | $248 | $9 |
| Lisinopril | 29 | $224 | $8 |
| Furosemide | 38 | $201 | $5 |
| Warfarin | 20 | $193 | $10 |
| Simvastatin | 23 | $174 | $8 |
| Alendronate | 16 | $138 | $9 |
| Losartan | 18 | $116 | $6 |
| Amlodipine Besylate | 18 | $109 | $6 |
| Spironolactone | 11 | $81 | $7 |
2013: 3 drugs
| Carvedilol | 17 | $186 | $11 |
| Lisinopril | 19 | $179 | $9 |
| Furosemide | 15 | $56 | $4 |
Money from drug and device companies
$664 in 2025
| 2025 | 3 | 4 | None | $664 |
| 2024 | 2 | 2 | None | $211 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Analog Devices | Sensinel Cpm Wearable | $295 | 2 payments
|
| Abiomed | None | $203 | 1 payment
|
| Scpharmaceuticals | Furoscix | $167 | 1 payment
|
See all 4 published payments
| Analog Devices | Meals · 2025-09-29 | Sensinel Cpm Wearable | $108 |
| Analog Devices | Meals · 2025-09-27 | Sensinel Cpm Wearable | $187 |
| Scpharmaceuticals | Meals · 2025-09-26 | Furoscix | $167 |
| Abiomed | Meals · 2025-03-20 | None | $203 |
See earlier years (2024)
2024: $211
| Abiomed | Impella | $114 | 1 payment
|
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $98 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| ENDOTRONIX, INC. · Proactive-Hf · 2024 | Their institution | $183,682 |
| ENDOTRONIX, INC. · Proactive-Hf · 2022 | Their institution | $32,714 |
| ENDOTRONIX, INC. · Proactive-Hf · 2023 | Their institution | $8,700 |
| Abbott Laboratories · Multi-Center Study of Maglev Technology in Patients Undergoing Mcs Therapy With Heartmate 3 Continued Access Protocol · 2019 | Their institution | $2,250 |
Professional record
- NPI
- 1861683559
- Licence
- CA C150453, IL 036136680California C150453: Current · expires 2027-03-31Illinois 036136680: Not Renewed
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 710 Lawrence Expy Dept 342, Santa Clara, CA, 95051
- NPI first listed
- 2007-08-07
- NPI last updated
- 2021-12-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 180 Harvester Dr, Burr Ridge, IL, 60527
This office lists an electronic records connection.